FDA Approved: EPRONTIA — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves EPRONTIA (topiramate) from Azurity Pharmaceuticals, Inc. via an original application for approved indications in epilepsy and migraine prophylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Migraine

Drugs mentioned

• EPRONTIA (Topiramate)

Snippet

ORIG AP for EPRONTIA (TOPIRAMATE)